Press Releases
December 26, 2025
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)
Indeterminate
GlobeNewswire, Inc.
December 26, 2025
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Indeterminate
GlobeNewswire, Inc.
December 26, 2025
Pulse Medical Assistant School Announces Winter 2026 Opening for 16-Week Program in Little Rock
Neutral
EIN Presswire
December 26, 2025
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
Indeterminate
GlobeNewswire, Inc.
December 26, 2025
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
Indeterminate
GlobeNewswire, Inc.
December 26, 2025
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Indeterminate
GlobeNewswire, Inc.
December 26, 2025
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
Indeterminate
GlobeNewswire, Inc.
December 25, 2025
Inspire Medical (INSP) Crashes Over 32%, “Inspire V” Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5
Indeterminate
GlobeNewswire, Inc.
December 25, 2025
Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm
Indeterminate
GlobeNewswire, Inc.
December 25, 2025
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Indeterminate
GlobeNewswire, Inc.
December 24, 2025
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
Indeterminate
GlobeNewswire, Inc.
December 25, 2025
Luoming PSA Medical Oxygen Generator: Enhancing Hospital Oxygen Supply Efficiency and Safety
Neutral
EIN Presswire
December 26, 2025
Gold Star Distribution Inc., Issues Recall of Certain FDA-Regulated Products in Three States Including Drugs, Devices, Cosmetics, Human Foods, and Pet Foods
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
December 26, 2025
Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Indeterminate
GlobeNewswire, Inc.